Skip to content
SpinTech Online

Zimbabwe Declines ‘Lopsided’ American Health Aid Agreement Due to Data Apprehensions

Health funding illustration
The offered US financial assistance would have supported programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has declined a significant US health deal worth 367 million US dollars (£272m) spanning five years because of the United States' request for confidential biological samples.

The decision came to light after a official document from December was leaked, revealing that President Emmerson Mnangagwa believed the agreement was "unbalanced".

An official spokesman has since stated that the US was seeking health data for scientific study and profit while refused to guarantee the resulting advantages from any future medical innovations.

"We are forced to start the challenging and unfortunate process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has called for continued dialogue to reach a deal acceptable to both sides so the country's critical HIV programme can proceed.

Wider Implications

This development follows a comparable case in Kenya, where a high court blocked a related deal with the US after legal challenges were raised about the security of citizens' health data.

Since resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had administered aid for the American government, but Trump claimed its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance transparency and responsibility.

According to statements, 16 African countries have so far agreed to these new health pacts, representing more than $18.3bn in new funding.

Details of the Declined Deal

The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this partnership might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via American-funded programmes," the Ambassador said.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," he stated.

"In essence, our country would provide the raw materials for scientific discovery with no assurance that the final treatments would be available to our citizens should a future disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were disrupting frameworks previously established through the global health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage future global health emergencies.

"This system is intended to ensure that when a country contributes its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the capability to develop them."

Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We welcome continued dialogue with our American counterparts on how subsequent co-operation might be designed in a manner that respects the independence and dignity of each country."

Medical Community Reaction

A leading public health body said it acknowledged the government's concerns, but suggested that talks should continue since much of the nation's HIV programmes relied on foreign aid.

"If technical issues arise, including those relating to information security or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," the group added.

The situation highlights the ongoing challenges between accepting crucial foreign assistance and protecting a country's data in an ever more data-driven world.

Written by

Chelsea Edwards

A tech journalist with over a decade of experience covering UK startups and digital transformation.

SpinTech Online

Type to search articles.